Prostate Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Men aged between 40 and 75 years old at the time of joining the trial
- People who are willing to sign and date a consent form agreeing to take part
- People who have had a standard PSA blood test result between 2 and 10 ng/mL within the last 30 days (a PSA test is a blood test used to check prostate health)
- People who are already scheduled to have a prostate biopsy (a procedure where a small tissue sample is taken from the prostate) within 30 days of their screening visit
- People who agree to share all their diagnostic test results throughout the study
- People who agree to provide a blood sample for two specific prostate-related tests (called Proclarix® and phi testing) at the screening visit
Who may not be able to join:
- No exclusion criteria have been listed for this trial (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 858-202-2000
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Assess the clinical performance of Proclarix® in a United States (US) cohort when compared to the biopsy results.
Can't join this trial?
Data last synced from ClinicalTrials.gov: 6 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.